TD Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-74,186
| Closed | -$1.5M | – | 1574 |
|
|
2021
Q3 | $1.5M | Hold |
74,186
| – | – | ﹤0.01% | 1160 |
|
|
2021
Q2 | $2.78M | Buy |
74,186
+18,400
| +33% | +$690K | ﹤0.01% | 991 |
|
|
2021
Q1 | $1.43M | Sell |
55,786
-10,094
| -15% | -$258K | ﹤0.01% | 1187 |
|
|
2020
Q4 | $1.45M | Hold |
65,880
| – | – | ﹤0.01% | 1102 |
|
|
2020
Q3 | $1.19M | Hold |
65,880
| – | – | ﹤0.01% | 1056 |
|
|
2020
Q2 | $1.67M | Buy |
65,880
+1,800
| +3% | +$45.7K | ﹤0.01% | 923 |
|
|
2020
Q1 | $1.18M | Sell |
64,080
-9,200
| -13% | -$169K | ﹤0.01% | 957 |
|
|
2019
Q4 | $1.61M | Buy |
73,280
+18,300
| +33% | +$403K | ﹤0.01% | 975 |
|
|
2019
Q3 | $790K | Buy |
54,980
+1,500
| +3% | +$21.6K | ﹤0.01% | 1100 |
|
|
2019
Q2 | $842K | Buy |
53,480
+16,500
| +45% | +$260K | ﹤0.01% | 1083 |
|
|
2019
Q1 | $542K | Buy |
36,980
+21,180
| +134% | +$310K | ﹤0.01% | 1178 |
|
|
2018
Q4 | $169K | Buy |
+15,800
| New | +$169K | ﹤0.01% | 1359 |
|